Fasting serum insulin levels also decreased by up to 70.9% after 48 weeks, which may improve insulin resistance but may require additional monitoring in certain patients
GLP-1 receptor agonists (GLP-1-RA) were first developed for the treatment of type-2 diabetes, but have been recently approved for treatment of obesity
They may work by increasing insulin secretion, improving insulin sensitivity, reducing glucose production in the liver, slowing carbohydrate absorption, or increasing glucose excretion through the kidneys
Taking this step is a responsible and proactive approach to your health
The whole ecosystem is making it easier than ever for impressionable people to jab themselves full of strange concoctions in order to hop on the peptide bandwagon
Additional savings on top of the lowest available cash price for GLP-1s: Patients can combine savings on their Body membership with access to the lowest cash prices for branded GLP-1s and additional saving options on Wegovy
